←Back to Expert Scholars
Translational Medicine / 转化医学Allogeneic HCT, Cord Blood and Cell Therapy
Marcos de Lima
MD
🏢Ohio State University Comprehensive Cancer Center🌐USA
Director, Bone Marrow Transplant Program
75
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Marcos de Lima directs HCT at Ohio State and has led trials of ex vivo expanded cord blood products and haploidentical transplants. His work bridges allogeneic HCT with novel cellular therapies. He contributes to international transplant guidelines.
Share:
🧪Research Fields 研究领域
cord blood transplant
ex vivo expansion
AML transplant
cell therapy
allogeneic HCT
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Marcos de Lima 的研究动态
Follow Marcos de Lima's research updates
留下邮箱，当我们发布与 Marcos de Lima（Ohio State University Comprehensive Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment